Medacta Group SA Stock Price

SWX:MOVE Community·CHF 2.7b Market Cap

1 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Create Narrative

MOVE Share Price Performance

CHF 133.80

1.40 (1.06%)

CHF 179.08

Fair Value

CHF 133.80

1.40 (1.06%)

25.3% undervalued

CHF 179.08

Fair Value

CHF 133.80

CHF 179.08

Fri, 5 Jun 26

Fair ValueCHF 179.08

Share Pricen/a

MOVE Community Narratives

AnalystConsensusTarget's

Fair Value

Fair Value CHF 179.08 25.3% undervalued

Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets

Medacta Group

Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets

Medacta is pushing into new regions and sports medicine while rolling out new knee products and training surgeons to use its tools, aiming to win share in a competitive market. The big question is whether heavier spending, acquisition integration, and currency swings could slow progress just as industry growth cools.Read more

CHF 179.08

25.3% undervalued

AnalystConsensusTarget's

Fair Value

Revenue

11.91% p.a.

Profit Margin

14.38%

Future PE

30.68x

Price in 2029

CHF 195.62

Trending Discussion

Snowflake Analysis

Outstanding track record with flawless balance sheet.

0 Risks

4 Rewards

View Full Analysis

Medacta Group SA Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

Sep 09, 2026

: 4.79
: 67.07%
: 13.96%
: 44.9%

View Full Analysis

About MOVE

Founded: 1958
Employees: 2036
CEO: Francesco Siccardi
WebsiteView website: www.medacta.com

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.